Role of codeine in palliative care

Journal of Opioid Management

Volumn 7, Issue 5, 2011, Pages 401-406

  Prommer, Eric ^a  

^a MAYO CLINIC HOSPITAL   (United States)

Author keywords

Codeine; Cough; Cytochrome oxidase; Opioids

Indexed keywords

CODEINE; CODEINE 6 GLUCURONIDE; CYTOCHROME C OXIDASE; DICLOFENAC; DIHYDROCODEINE; DRUG METABOLITE; FENTANYL; HYDROCODONE; IMIPRAMINE; LEVDROPROPIZINE; MORPHINE; NORCODEINE; PARACETAMOL; QUINIDINE;

AEROBIC METABOLISM; ANALGESIC ACTIVITY; CANCER PAIN; CLINICAL TRIAL (TOPIC); CONSTIPATION; COUGHING; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG METABOLISM; DYSPNEA; GLUCURONIDATION; HUMAN; NAUSEA; PAIN; PAIN ASSESSMENT; PALLIATIVE THERAPY; REVIEW; SUSTAINED DRUG RELEASE; SYSTEMATIC REVIEW; VOMITING; XEROSTOMIA;

ANALGESICS, OPIOID; CODEINE; DIARRHEA; HUMANS; PAIN; PALLIATIVE CARE; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 81855200108     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2011.0081     Document Type: Review

References (39)

1. De Lima L, Krakauer EL, Lorenz K, et al.: Ensuring palliative medicine availability: The development of the IAHPC list of essential medicines for palliative care. J Pain Symptom Manage. 2007; 33(5): 521-526. (Pubitemid 46680389)
2. World Health Organization: Essential medicines: Definition and concept Available at http://www.who.int/medicines/services/essmedicines-def/en/index. html. Accessed December 6, 2006.
3. De Lima L, Sweeney C, Palmer JL, et al.: Potent analgesics are more expensive for patients in developing countries. J Pain Palliative Care Pharmacother. 2004; 18(1): 59-70. (Pubitemid 38747718)
4. Cherny NI: The problem of suffering and the principles of assessment in palliative medicine. In Hanks G, Cherny NI, Christakis NA, Fallon M, Kaasa S, Portenoy RK (eds): Oxford Textbook of Palliative Medicine. 4th ed. Oxford: Oxford University Press, 2010; Section 3: 43-58.
5. Trescot AM, Datta S, Lee M, et al.: Opioid pharmacology. Pain Physician. 2008; 11(2 Suppl): S133-S153. (Pubitemid 351682083)
6. Roy SD, Flynn GL: Solubility and related physicochemical properties of narcotic analgesics. Pharm Res. 1988; 5(9): 580-586.
7. Gourlay GK: Advances in opioid pharmacology. Support Care Cancer. 2005; 13(3): 153-159.
8. Coller JK, Christrup LL, Somogyi AA: Role of active metabolites in the use of opioids. Eur J Clin Pharmacol. 2009; 65(2): 121-139.
9. Ebert B, Andersen S, Krogsgaard-Larsen P: Ketobemidone, methadone and pethidine are non-competitive N-methyl-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett. 1995; 187(3): 165-168.
10. Lötsch J: Opioid metabolites. J Pain Symptom Manage. 2005; 29(5, Suppl 1): 10-24.
11. Srinivasan V, Wielbo D, Simpkins J, et al.: Analgesic and immunomodulatory effects of codeine and codeine 6-glucuronide. Pharm Res. 1996; 13(2): 296-300. (Pubitemid 26072151)
12. Mikus G, Weiss J: Influence of CYP2D6 genetics on opioid kinetics, metabolism and response. Curr Pharmacogenomics. 2005; 3(1): 43-52. (Pubitemid 40352698)
13. Projean D, Morin PE, Tu TM, et al.: Identification of CYP3A4 and CYP2C8 as the major cytochrome P450 s responsible for morphine N-demethylation in human liver microsomes. Xenobiotica. 2003; 33(8): 841-854. (Pubitemid 37129907)
14. Talbott GA, Lynn AM, Levy FH, et al.: Respiratory arrest precipitated by codeine in a child with chronic renal failure. Clin Pediatr. 1997; 36(3): 171-173. (Pubitemid 27131796)
15. Dean M: Opioids in renal failure and dialysis patients. J Pain Symptom Manage. 2004; 28(5): 497-504.
16. Schiff L, Schiff ER: Diseases of the Liver. Philadelphia, PA: Lippincott, 1993.
17. Moore A, Collins S, Carroll D, et al.: Paracetamol with and without codeine in acute pain: A quantitative systematic review. Pain. 1997; 70(2-3): 193-201. (Pubitemid 27179631)
18. Minotti V, Patoia L, Roila F, et al.: Double-blind evaluation of analgesic efficacy of orally administered diclofenac, nefopam, and acetylsalicylic acid (ASA) plus codeine in chronic cancer pain. Pain. 1989; 36(2): 177-183. (Pubitemid 19045576)
19. Dhaliwal HS, Sloan P, Arkinstall WW, et al.: Randomized evaluation of controlled-release codeine and placebo in chronic cancer pain. J Pain Symptom Manage. 1995; 10(8): 612-623.
20. Rodriguez RF, Castillo JM, Castillo MP, et al.: Hydrocodone/acetaminophen and tramadol chlorhydrate combination tablets for the management of chronic cancer pain: A double-blind comparative trial. Clin J Pain. 2008; 24(1): 1-4.
21. Pistevou-Gompaki K, Kouloulias VE, Varveris C, et al.: Radiotherapy plus either transdermal fentanyl or paracetamol and codeine for painful bone metastases: A randomised study of pain relief and quality of life. Curr Med Res Opin. 2004; 20(2): 159-163. (Pubitemid 38197316)
22. Chua TP, Harrington D, Ponikowski P, et al.: Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol. 1997; 29(1): 147-152. (Pubitemid 27028732)
23. Johnson MA, Woodcock AA, Geddes DM: Dihydrocodeine for breathlessness in "pink puffers". Br Med J. 1983; 286(6366): 675-677.
24. Woodcock AA, Gross ER, Gellert A, et al.: Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. N Engl J Med. 1981; 305(27): 1611-1616. (Pubitemid 12169189)
25. Baldi F, Bianco MA, Nardone G, et al.: Focus on acute diarrhoeal disease. World J Gastroenterol. 2009; 15(27): 3341-3348.
26. Nwachukwu CE, Okebe JU: Antimotility agents for chronic diarrhoea in people with HIV/AIDS. Cochrane Database Syst Rev. 2008; (4): CD005644.
27. Freestone C, Eccles R: Assessment of the antitussive efficacy of codeine in cough associated with common cold. J Pharm Pharmacol. 1997; 49(10): 1045-1049. (Pubitemid 27478402)
28. Luporini G, Barni S, Marchi E, et al.: Efficacy and safety of levodropropizine and dihydrocodeine on nonproductive cough in primary and metastatic lung cancer. Eur Respir J. 1998; 12(1): 97-101. (Pubitemid 28325660)
29. Smith J, Owen E, Earis J, et al.: Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2006; 117(4): 831-835.
30. Band CJ, Band PR, Deschamps M, et al.: Human pharmacokinetic study of immediate-release (codeine phosphate) and sustained-release (codeine Contin) codeine. J Clin Pharmacol. 1994; 34(9): 938-943. (Pubitemid 24321080)
31. Desmeules J, Gascon MP, Dayer P, et al.: Impact of environmental and genetic factors on codeine analgesia. Eur J Clin Pharmacol. 1991; 41(1): 23-26.
32. Poulsen L, Brosen K, Arendt-Nielsen L, et al.: Codeine and morphine in extensive and poor metabolizers of sparteine: Pharmacokinetics, analgesic effect and side effects. Eur J Clin Pharmacol. 1996; 51(3): 289-295. (Pubitemid 26422976)
33. Codd EE, Shank RP, Schupsky JJ, et al.: Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: Structural determinants and role in antinociception. J Pharmacol Exp Ther. 1995; 274(3): 1263-1270.
34. Beaver WT, Wallenstein SL, Rogers A, et al.: Analgesic studies of codeine and oxycodone in patients with cancer. I. Comparisons of oral with intramuscular codeine and of oral with intramuscular oxycodone. J Pharmacol Exp Ther. 1978; 207(1): 92-100. (Pubitemid 9016587)
35. Beaver WT, Wallenstein SL, Rogers A, et al.: Analgesic studies of codeine and oxycodone in patients with cancer. II. Comparisons of intramuscular oxycodone with intramuscular morphine and codeine. J Pharmacol Exp Ther. 1978; 207(1): 101-108. (Pubitemid 9016588)
36. Fallon M, Cherny NI, Hanks G, et al.: Opioid Therapy. In Oxford Textbook of Palliative Medicine. 4th ed. Oxford: Oxford University Press, 2010; Section 10: 661-698.
37. Sevelius H, McCoy JF, Colmore JP: Dose response to codeine in patients with chronic cough. Clin Pharmacol Ther. 1971; 12(3): 449-455.
38. Estfan B, LeGrand S: Management of cough in advanced cancer. J Support Oncol. 2004; 2(6): 523-527. (Pubitemid 40100642)
39. Woodcock AA, Johnson MA, Geddes DM: Breathlessness, alcohol and opiates. N Engl J Med. 1982; 306(22): 1363-1364.